An interventional study of Virtual Reality Training in Stroke, sponsored by McGill University. Recruiting at 1 site in Canada. Open to participants aged 40 Years to 84 Years. Per ClinicalTrials.gov, last updated 2026-03-20.
Sponsored by McGill University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Stroke by McGill University — 7 open to participants now, 7 under way, none of them phase 3. Stroke · McGill University.
Among the 16 studies in Stroke by McGill University, this one is the 8th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2026, is one of 15 with no phase, and was the 15th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 16 studies in Stroke by McGill University are open now, in 1 country. Recruiting first, the newest first:
McGill University · Sites in Canada
Ages 40–80
McGill University · Sites in Canada
Ages 40–74
McGill University · Sites in Canada
Ages 18–85
McGill University · Sites in Canada
Ages 40–74
McGill University · Sites in Canada
Ages 40–80
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 40 Years to 84 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 40 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 15 interventional studies, 12 across the 1 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
McGill University is the lead sponsor of 249 studies on the registry; 50 are open to participants now.
4 of the studies in Stroke by McGill University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07201974McGill UniversityVirtual Reality for Post-Stroke Gait Rehabilitation | 2026-11 |
| NCT06621771McGill UniversityPlaying Piano to Improve Hand Function Early After Stroke | 2027-05-01 |
| NCT04559373McGill UniversityVirtual Reality and Field Training to Enhance Community Walking After Stroke | 2027-05-31 |
| NCT07178535McGill UniversityFeasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke | 2027-07-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Stroke by McGill University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting.
Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5. For each demand, patients will progress through levels of increasing difficulty according to personalized goals and success criteria.
The project involves the VR-ODT set-up and intervention aimed at improving community walking in stroke survivors, to be implemented and tested within the clinical setting. The set-up comprises of a VR headset (HTC Vive) and an ODT (Infinadeck- to our knowledge the only one in Canada) allowing users to walk at self-selected speed in any direction (360 degrees) in a virtual environment representing a shopping mall in Montreal and nearby streets. Stroke individuals with an altered walking capacity (speed: 0.3 - 0.95m/s) will be recruited from the JRH in- and outpatient programs for 12 consecutive months.
Feasibility (Obj. 1) will be examined using the following measures collated post intervention: number of eligible vs. referred patients and treating clinicians involved; patient and clinician characteristics; adherence to the intervention and adverse events. Perceived mental and physical demands (NASA Tax Load Index), sense of presence (Single- Item Presence Questionnaire) and cybersickness (Simulator Sickness Questionnaire) will also be assessed. Acceptability (Obj. 2) patients and clinicians will be assessed using a Technology Acceptance Model Questionnaire that includes questions related to perceived ease of use and usefulness, as well as with open-ended questions. To optimize uptake and sustainability (Obj. 3), two clinicians (1 occupationnel therapist \& 1 physiotherapist) from the JRH stroke program will be trained as clinician-champions (CC) on using the VR-ODT intervention and supporting other clinicians with intervention delivery. The CC, in collaboration with the team, will generate instructional materials (written and video) that detail the intervention, targeted users and step-by-step procedures for clinical use. The CC will also be involved in demonstrations (X2) on the use of the intervention for clinicians. They will be the resource for any question or required assistance with the VR-ODT set-up \& intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation Hospital (CISSS Laval) for mobility problems over a period of 6 months will be recruited. They will:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will engage in a 4-week VR intervention that comprises of 1-hour training sessions, 2 times/week.
Other: Virtual Reality Training
The VR intervention involves the intensive practice of community ambulation skills. The training sessions will be performed in a virtual environment. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.
Feasibility: adherence to intervention - number of completed sessions
Training logbook filled by clinicians
Time frame: 2x/week over the 4-week intervention
Feasibility: presence of adverse or undesirable effects during the intervention
Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc). Collected with open-ended questions.
Time frame: Post-Intervention (week4)
Feasibility: Number of participants recruited in each program
Number of early discharged participants vs. outpatient program participants
Time frame: Pre-intervention (week0)
Feasibility: Characteristics of stroke participants: age
Collected via medical charts
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: sex
Collected via medical charts
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: gender
Collected via medical charts
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: walking capacity
Collected via medical charts. According to physiotherapy evaluations, walking capacity is characterized as severely, moderately or mildly affected.
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: cognitive function
Collected via medical charts. According to occupationnal therapy evaluations, cognitive fonction is characterised as severely affected, moderately affected, mildly affected, or intact.
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: visual-perceptual function
Collected via medical charts. According to occupationnal therapy evaluations, visual-perceptual function is characterised as severely affected, moderately affected, mildly affected, or intact.
Time frame: Pre-intervention (week 0)
Feasibility: Characteristics of clinicians
collected via paper-based questionnaire
Time frame: Pre-intervention (week0)
Feasibility: Number of eligible vs. referred participants
Assessed using the number of participants referred to the study in comparison to the list of admitted patients in the targeted stroke programs.
Time frame: Post-intervention (week4)
Feasibility: Perceived mental and physical demands
Collected using the NASA Tax Load Index. It assesses work load on five 7-point scales. Increments of high, medium and low estimates for each point result in 21 gradations on the scales.
Time frame: Post-Intervention (week4)
Feasibility: Sense of presence
Collected with the Single-Item Presence Questionnaire, a brief measure used to assess a participant's sense of presence in a virtual environment. It consists of one question rated on a 7-point Likert scale, ranging from 1 ("not at all") to 7 ("completely").
Time frame: Post-Intervention (week4)
Feasibility: Presence of cybersickness
Collected via the Simulator Sickness Questionnaire, used for assessing symptoms of motion or simulator sickness following exposure to virtual environments. It includes 16 symptoms rated on a 4-point scale from 0 ("none") to 3 ("severe"), covering nausea, oculomotor discomfort, and disorientation.
Time frame: Post-Intervention (week4)
Acceptability of the intervention
Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which participants (patients and cliniciens) will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention.
Time frame: Post-intervention (Week4)
Acceptability: Overall experience
Investigated through open-ended questions
Time frame: Post-Intervention (Week4)
Plan to share: Yes — De-identified individual participant data for all primary and secondary outcome measure will be made available.
Time frame: Data will be available within 6 months of study completion
Access criteria: De-identified data will be deposited in a REDCap database and made available to collaborators. Data may also be made available to other researchers via an institutional data repository that will allow adhering to FAIR principles.
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 9 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.